Ranbaxy launches Italian biz

Continuing its expansion in Europe, Ranbaxy Laboratories Ltd on Tuesday said it has entered into the Italian pharmaceutical market with the launch of a wholly owned subsidiary, Ranbaxy Italia SPA,......

Ranbaxy loses exclusivity on heartburn drug in US

  Drug maker Ranbaxy’s troubles with the US Food and Drug Administration (FDA) continue, with the American regulator allowing Israel-based Teva Pharma to launch the generic of Nexium, a......

Ranbaxy sues US FDA for revoking drug approvals

FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte Ranbaxy Laboratories Ltd has sued the US Food and Drug Administration (FDA) for revoking approvals granted to the firm to......

Sun denies insider trading charges in Ranbaxy deal

Sun Pharma on Wednesday denied insider trading charges against Silverstreet Developers LLP -- its wholly owned arm -- in the $4 billion acquisition deal of Ranbaxy Laboratories. Silverstreet......